Literature DB >> 32372016

UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53.

Yexiang Huang1, Yuyan Zhu1, Zhe Zhang1, Zhenhua Li1, Chuize Kong2.   

Abstract

UNC5B is a known tumor suppressor gene in a variety of cancers. As a transmembrane protein, UNC5B also induces apoptosis in a P53-dependent manner. In this study, we demonstrate that UNC5B inhibits proliferation through G2/M phase arrest by mass spectrometry and bioinformatics analysis in bladder cancer cells. By combing with CDC14A and P53, UNC5B dephosphorylated P53 at Ser-315 site. This dephosphorylation facilitated G2/M phase arrest by reducing the expression of cyclin B1 and increasing the expression of p-CDK1, thus inhibiting tumor proliferation. Knockdown of CDC14A suppressed the G2/M phase arrest induced by UNC5B in vitro, and eliminated the inhibitory effect of UNC5B on tumor proliferation in vivo. Our results show that UNC5B-mediated cell cycle arrest may act as a potential treatment for bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32372016     DOI: 10.1038/s41417-020-0175-x

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  40 in total

1.  International variations in bladder cancer incidence and mortality.

Authors:  Saurabh Chavan; Freddie Bray; Joannie Lortet-Tieulent; Michael Goodman; Ahmedin Jemal
Journal:  Eur Urol       Date:  2013-10-16       Impact factor: 20.096

Review 2.  Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer.

Authors:  Mario W Kramer; Vincenzo Altieri; Rodolfo Hurle; Lukas Lusuardi; Axel S Merseburger; Jens Rassweiler; Julian P Struck; Thomas R W Herrmann
Journal:  Eur Urol Focus       Date:  2017-01-11

Review 3.  Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle.

Authors:  Christian D Fankhauser; Hugh Mostafid
Journal:  Curr Opin Urol       Date:  2018-01       Impact factor: 2.309

Review 4.  Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies.

Authors:  Daniel Zainfeld; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

Review 5.  Epidemiology and risk factors of urothelial bladder cancer.

Authors:  Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan
Journal:  Eur Urol       Date:  2012-07-25       Impact factor: 20.096

6.  Progression to T1 High Grade (T1HG) from a Lower Stage/Grade is Associated with Poorer Survival Outcomes than Initial Diagnosis with T1HG Bladder Cancer.

Authors:  Jung Kwon Kim; Chang Wook Jeong; Cheol Kwak; Hyun Hoe Kim; Ja Hyeon Ku
Journal:  Ann Surg Oncol       Date:  2017-05-30       Impact factor: 5.344

Review 7.  The health economics of bladder cancer: an updated review of the published literature.

Authors:  Christina Yeung; Tuan Dinh; Joseph Lee
Journal:  Pharmacoeconomics       Date:  2014-11       Impact factor: 4.981

Review 8.  Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.

Authors:  Jakub Dobruch; Siamak Daneshmand; Margit Fisch; Yair Lotan; Aidan P Noon; Matthew J Resnick; Shahrokh F Shariat; Alexandre R Zlotta; Stephen A Boorjian
Journal:  Eur Urol       Date:  2015-09-04       Impact factor: 20.096

9.  A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States.

Authors:  Erikka Loftfield; Neal D Freedman; Maki Inoue-Choi; Barry I Graubard; Rashmi Sinha
Journal:  Epidemiology       Date:  2017-09       Impact factor: 4.822

10.  Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World.

Authors:  Neda Mahdavifar; Mahshid Ghoncheh; Reza Pakzad; Zohre Momenimovahed; Hamid Salehiniya
Journal:  Asian Pac J Cancer Prev       Date:  2016
View more
  4 in total

1.  Targets for Renal Carcinoma Growth Control Identified by Screening FOXD1 Cell Proliferation Pathways.

Authors:  Kyle H Bond; Sunder Sims-Lucas; Leif Oxburgh
Journal:  Cancers (Basel)       Date:  2022-08-16       Impact factor: 6.575

2.  RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence.

Authors:  Joseph L Regan; Dirk Schumacher; Stephanie Staudte; Andreas Steffen; Ralf Lesche; Joern Toedling; Thibaud Jourdan; Johannes Haybaeck; Dominik Mumberg; David Henderson; Balázs Győrffy; Christian R A Regenbrecht; Ulrich Keilholz; Reinhold Schäfer; Martin Lange
Journal:  iScience       Date:  2021-05-24

3.  UNC5B Promotes Vascular Endothelial Cell Senescence via the ROS-Mediated P53 Pathway.

Authors:  Zhen Yang; Han Li; Pengcheng Luo; Dan Yan; Ni Yang; Yucong Zhang; Yi Huang; Yu Liu; Le Zhang; Jinhua Yan; Cuntai Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-06-20       Impact factor: 6.543

4.  Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway.

Authors:  Jochen Rutz; Sebastian Maxeiner; Eva Juengel; Felix K-H Chun; Igor Tsaur; Roman A Blaheta
Journal:  Nutrients       Date:  2022-01-15       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.